This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Reasons to Add Synovus (SNV) Stock to Your Portfolio Now
by Zacks Equity Research
Synovus (SNV) is well poised to gain from strategic mergers and acquisitions and balance sheet strength.
Why Is Synovus (SNV) Down 4.7% Since Last Earnings Report?
by Zacks Equity Research
Synovus (SNV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synovus (SNV) Thrives on Organic Growth Amid High Costs
by Zacks Equity Research
Synovus (SNV) continues to benefit from strong loans and deposit balances. Balance sheet strength and strong liquidity position is another positive.
Synovus Financial (SNV) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Synovus Financial (SNV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is First Trust SMID Cap Rising Dividend Achievers ETF (SDVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SDVY
Capital One (COF) Q2 Earnings Miss on Y/Y Increase in Provisions
by Zacks Equity Research
Capital One (COF) records y/y increases in revenues and expenses in the second quarter of 2024.
Synovus (SNV) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Synovus' (SNV) Q2 earnings benefit from a year-over-year decline in expenses and provisions. However, declining loan and deposit balances, along with lower NII, act as spoilsports.
Synovus (SNV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Synovus (SNV) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Synovus Financial (SNV) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of 20.83% and 38.35%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What Makes Synovus Financial (SNV) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Synovus Financial (SNV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ahead of Synovus (SNV) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Synovus (SNV) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Earnings Preview: Investar (ISTR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Investar (ISTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Synovus Financial (SNV) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Synovus (SNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synovus' (SNV) Organic Expansion Drives Growth, High Costs Ail
by Zacks Equity Research
Synovus (SNV) benefits from the strategic expansion efforts of its banking verticals. However, a rise in expenses is likely to impede bottom-line growth in the near term.
Synovus (SNV) Arm Ratings Affirmed by Moody's, Outlook Stable
by Zacks Equity Research
Moody's rating affirms Synovus' (SNV) subsidiary's ratings with a stable outlook. This shows a balance between the credit headwinds associated with a significant concentration in CRE loans.
Synovus (SNV) to Sell RWA & Reposition Securities Portfolio
by Zacks Equity Research
Synovus (SNV) plans to reduce risk-weighted assets by $2-$2.4 billion in second-quarter 2024 and sell available-for-sale securities with a book value of $1.6 billion.
Synovus (SNV) Q1 Earnings & Revenues Miss, Expenses Rise Y/Y
by Zacks Equity Research
Synovus' (SNV) Q1 results reflect y/y declines in revenues and loan balances, as well as increased expenses and provisions.
Compared to Estimates, Synovus (SNV) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Synovus (SNV) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Synovus Financial (SNV) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of -20.20% and 2.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Unveiling Synovus (SNV) Q1 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Synovus (SNV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Hilltop Holdings (HTH) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Hilltop Holdings (HTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Synovus Financial (SNV) Q1 Earnings Expected to Decline
by Zacks Equity Research
Synovus (SNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synovus (SNV) Rolls Out Accelerate Pay for Business Payments
by Zacks Equity Research
Synovus (SNV) unveils a payment solution, Accelerate Pay, to enable commercial banking clients to initiate account payable payments, while eliminating check payments.
JPMorgan's (JPM) Outlook Upgraded by S&P, Ratings Affirmed
by Zacks Equity Research
S&P Global Ratings upgrade JPMorgan's (JPM) outlook to positive from stable, reflecting the strength of the company's extensive lending-to-trading business.
Outlook on 5 Regional Banks Lowered by S&P on CRE Exposure
by Nikita Kataruka
S&P Ratings downgrades the outlook on First Commonwealth, M&T Bank (MTB), Synovus (SNV), Trustmark (TRMK) and Valley National (VLY) to negative from stable.